Shenzhen Hepalink Pharmaceutical Group. (9989.HK) Q2 2025 Earnings

24AprConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
0.08
0.18
0.28
0.38

Details

Expected EPS
0.096190010784
Actual EPS
0.11403860167391999
Surprise EPS
0.02
Surprise Percent
+18.56%

Description

Shenzhen Hepalink Pharmaceutical Group. (9989.HK) has reported earnings of 0.11403860167391999 per share for Q2 2025.

0 Comments

Share your thoughts